Throat Lozenges Market Study by Hard Candy Lozenges, Soft Lozenges, and Compressed Lozenges for Sore Throat, Cough & Cold, and Throat Diseases from 2024 to 2034

<p>Worldwide revenue from the sales of throat lozenges is approximated at <strong>US$ 5.97 billion</strong> in 2024 and is forecasted to rise at a <strong>CAGR of 5.1%</strong> to reach <strong>US$ 9.8 billion</strong> by the end of the years 2034.</p><table><thead><tr><th>Report Attributes</th><th>Details</th></tr></thead><tbody><tr><td>Throat Lozenges Market Size (2024E)</td><td>US$ 5.97 Billion</td></tr><tr><td>Forecasted Market Value (2034F)</td><td>US$ 9.8 Billion</td></tr><tr><td>Global Market Growth Rate (2024 to 2034)</td><td>5.1% CAGR</td></tr><tr><td>South Korea Market Value (2034F)</td><td>US$ 408.3 Million</td></tr><tr><td>Key Companies Profiled</td><td><ul><li>Bliss GVS Pharma Ltd.</li><li>SSL International</li><li>Cipla Ltd</li><li>Reckitt Benckiser Group Plc.</li><li>Ricola AG</li><li>GlaxoSmithKline Plc.</li><li>Honibe</li><li>Johnson &amp; Johnson</li><li>Thornton &amp; Ross Ltd.</li><li>Traditional Medicinals, Inc.</li><li>Prestige Consumer Healthcare Inc.</li><li>Sanofi S.A</li><li>Novartis</li></ul></td></tr></tbody></table><p>Comparative Analysis of Related Markets</p><table><thead><tr><th>Key Attributes</th><th>Throat Lozenges Market</th></tr></thead><tbody><tr><td>Forecasted Market Value (2034F)</td><td>US$ 9.80 Billion</td></tr><tr><td>Key Trend</td><td>Rising demand for herbal formulations</td></tr><tr><td>Growth Factor</td><td>Consumption of lozenges as first line of treatment</td></tr></tbody></table><table><thead><tr><th>Key Attributes</th><th>Natural Cold, Cough, and Sore Throat Remedies Market</th></tr></thead><tbody><tr><td>Forecasted Market Value (2034F)</td><td>US$ 12 Billion</td></tr><tr><td>Key Trend</td><td>Evolving consumer preferences and increasing popularity of self-healing approach</td></tr><tr><td>Growth Factor</td><td>Rising prevalence of respiratory disorders</td></tr></tbody></table><table><thead><tr><th>Key Attributes</th><th>OTC Cough, Cold and Allergy Medicine Market</th></tr></thead><tbody><tr><td>Forecasted Market Value (2034F)</td><td>US$ 70 Billion</td></tr><tr><td>Key Trend</td><td>Growing shift from Rx to OTC</td></tr><tr><td>Growth Factor</td><td>Easy availability of medicine without need of valid prescription</td></tr></tbody></table><p>Country-wise Analysis</p><table><thead><tr><th>Attribute</th><th>United States</th></tr></thead><tbody><tr><td>Market Value (2024E)</td><td>US$ 1.94 Billion</td></tr><tr><td>Growth Rate (2024 to 2034)</td><td>6% CAGR</td></tr><tr><td>Projected Value (2034F)</td><td>US$ 3.46 Billion</td></tr></tbody></table><table><thead><tr><th>Attribute</th><th>South Korea</th></tr></thead><tbody><tr><td>Market Value (2024E)</td><td>US$ 242.1 Million</td></tr><tr><td>Growth Rate (2024 to 2034)</td><td>5.4% CAGR</td></tr><tr><td>Projected Value (2034F)</td><td>US$ 408.3 Million</td></tr></tbody></table><p>Category-wise Analysis</p><table><thead><tr><th>Attribute</th><th>Hard Candy Lozenges</th></tr></thead><tbody><tr><td>Segment Value (2024E)</td><td>US$ 3.78 Billion</td></tr><tr><td>Growth Rate (2024 to 2034)</td><td>5.1% CAGR</td></tr><tr><td>Projected Value (2034F)</td><td>US$ 6.23 Billion</td></tr></tbody></table><table><thead><tr><th>Attribute</th><th>Sore Throat</th></tr></thead><tbody><tr><td>Segment Value (2024E)</td><td>US$ 3.14 Billion</td></tr><tr><td>Growth Rate (2024 to 2034)</td><td>5.2% CAGR</td></tr><tr><td>Projected Value (2034F)</td><td>US$ 5.21 Billion</td></tr></tbody></table>

<p>全球喉糖销售额预计在2024年达到约<strong>59.7亿美元</strong>，并预计将以<strong>5.1%的复合年增长率</strong>增长，至2034年底达到<strong>98亿美元</strong>。</p><table><thead><tr><th>报告属性</th><th>详细信息</th></tr></thead><tbody><tr><td>喉糖市场规模（2024E）</td><td>59.7亿美元</td></tr><tr><td>预测市场价值（2034F）</td><td>98亿美元</td></tr><tr><td>全球市场增长率（2024至2034年）</td><td>5.1% CAGR</td></tr><tr><td>韩国市场价值（2034F）</td><td>4.083亿美元</td></tr><tr><td>主要公司简介</td><td><ul><li>Bliss GVS Pharma Ltd.</li><li>SSL International</li><li>Cipla Ltd</li><li>Reckitt Benckiser Group Plc.</li><li>Ricola AG</li><li>GlaxoSmithKline Plc.</li><li>Honibe</li><li>Johnson &amp; Johnson</li><li>Thornton &amp; Ross Ltd.</li><li>Traditional Medicinals, Inc.</li><li>Prestige Consumer Healthcare Inc.</li><li>Sanofi S.A</li><li>Novartis</li></ul></td></tr></tbody></table><p>相关市场比较分析</p><table><thead><tr><th>关键属性</th><th>喉糖市场</th></tr></thead><tbody><tr><td>预测市场价值（2034F）</td><td>98亿美元</td></tr><tr><td>主要趋势</td><td>对草本配方的需求不断上升</td></tr><tr><td>增长因素</td><td>喉糖作为一线治疗手段的消费增加</td></tr></tbody></table><table><thead><tr><th>关键属性</th><th>天然感冒、咳嗽和喉咙痛药物市场</th></tr></thead><tbody><tr><td>预测市场价值（2034F）</td><td>120亿美元</td></tr><tr><td>主要趋势</td><td>消费者偏好演变及自愈方法的日益流行</td></tr><tr><td>增长因素</td><td>呼吸道疾病发病率的上升</td></tr></tbody></table><table><thead><tr><th>关键属性</th><th>非处方咳嗽、感冒和过敏药物市场</th></tr></thead><tbody><tr><td>预测市场价值（2034F）</td><td>700亿美元</td></tr><tr><td>主要趋势</td><td>从处方药向非处方药的转变日益加剧</td></tr><tr><td>增长因素</td><td>无需有效处方即可轻松获得药物</td></tr></tbody></table><p>按国家分析</p><table><thead><tr><th>属性</th><th>美国</th></tr></thead><tbody><tr><td>市场价值（2024E）</td><td>19.4亿美元</td></tr><tr><td>增长率（2024至2034年）</td><td>6% CAGR</td></tr><tr><td>预测价值（2034F）</td><td>34.6亿美元</td></tr></tbody></table><table><thead><tr><th>属性</th><th>韩国</th></tr></thead><tbody><tr><td>市场价值（2024E）</td><td>2.421亿美元</td></tr><tr><td>增长率（2024至2034年）</td><td>5.4% CAGR</td></tr><tr><td>预测价值（2034F）</td><td>4.083亿美元</td></tr></tbody></table><p>按类别分析</p><table><thead><tr><th>属性</th><th>硬糖喉糖</th></tr></thead><tbody><tr><td>细分市场价值（2024E）</td><td>37.8亿美元</td></tr><tr><td>增长率（2024至2034年）</td><td>5.1% CAGR</td></tr><tr><td>预测价值（2034F）</td><td>62.3亿美元</td></tr></tbody></table><table><thead><tr><th>属性</th><th>喉咙痛</th></tr></thead><tbody><tr><td>细分市场价值（2024E）</td><td>31.4亿美元</td></tr><tr><td>增长率（2024至2034年）</td><td>5.2% CAGR</td></tr><tr><td>预测价值（2034F）</td><td>52.1亿美元</td></tr></tbody></table>